The pharma company's revenue from operations rose 12 percent to Rs 1,614.28 crore in Q3 of the current financial year. The ...

Abbott Laboratories engages in the discovery ... markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Jan 22 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand ...

Abbott Laboratories and Decom will concentrate on competing in the huge market of potential continuous glucose monitor technology and put any patent disputes behind them for 10 years. North ...